Cyclerion Therapeutics (NASDAQ:CYCN) Shares Down 6.2%

Share on StockTwits

Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s share price was down 6.2% on Thursday . The company traded as low as $1.79 and last traded at $1.82, approximately 682,400 shares traded hands during trading. An increase of 152% from the average daily volume of 270,909 shares. The stock had previously closed at $1.94.

The stock’s 50-day moving average is $8.00 and its two-hundred day moving average is $10.82. The company has a current ratio of 6.60, a quick ratio of 6.60 and a debt-to-equity ratio of 0.51.

Cyclerion Therapeutics (NASDAQ:CYCN) last issued its quarterly earnings data on Monday, August 12th. The company reported ($1.18) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.84) by ($0.34). The company had revenue of $1.63 million for the quarter.

A number of institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. bought a new position in Cyclerion Therapeutics during the third quarter valued at approximately $1,112,000. First Trust Advisors LP bought a new position in Cyclerion Therapeutics during the third quarter valued at approximately $430,000. California Public Employees Retirement System bought a new position in Cyclerion Therapeutics during the third quarter valued at approximately $404,000. Finally, Broderick Brian C bought a new position in Cyclerion Therapeutics during the third quarter valued at approximately $399,000. Institutional investors own 71.38% of the company’s stock.

About Cyclerion Therapeutics (NASDAQ:CYCN)

There is no company description available for Cyclerion Therapeutics Inc

Recommended Story: Investing in Growth Stocks

Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.